Deficiencies Force Pfizer to Shut Down Indian Facility Temporarily

MUMBAI: Pfizer is the latest addition to an expanding list of drug makers found deviating from good manufacturing practices in India. In the last week of June, a high profile team drawn from world's four leading regulators identified a number of deficiencies at the company's Irungattukottai facility, near Chennai. Pfizer has temporarily stopped production at the site.

The site, which makes generic injectable drugs, is grappling with adverse reviews for a few years.